Hope for thousands as NHS approves drug for acute migraine
by Denis Campbell Health policy editor from Science | The Guardian on (#6EQW3)
First and only Nice-recommended medicine could alleviate misery' of condition in England and Wales
NHS health advisers have approved the first treatment for acute migraine in a decision that promises to bring relief to about 13,000 people.
The National Institute of Health and Clinical Excellence (Nice) has recommended a drug called rimegepant, also known as Vydura, which is made by Pfizer.
Continue reading...